MPWT
MassMutual Private Wealth & Trust’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $61.8K | Sell |
492
-66
| -12% | -$8.3K | ﹤0.01% | 720 |
|
|
2025
Q1 | $61.7K | Buy |
558
+27
| +5% | +$2.99K | ﹤0.01% | 674 |
|
|
2024
Q4 | $72.5K | Buy |
531
+157
| +42% | +$21.4K | ﹤0.01% | 645 |
|
|
2024
Q3 | $43.1K | Sell |
374
-138
| -27% | -$15.9K | ﹤0.01% | 696 |
|
|
2024
Q2 | $70.5K | Buy |
512
+155
| +43% | +$21.3K | ﹤0.01% | 575 |
|
|
2024
Q1 | $49.2K | Buy |
357
+11
| +3% | +$1.52K | ﹤0.01% | 623 |
|
|
2023
Q4 | $45.6K | Buy |
346
+9
| +3% | +$1.19K | ﹤0.01% | 626 |
|
|
2023
Q3 | $37.9K | Buy |
337
+86
| +34% | +$9.68K | ﹤0.01% | 661 |
|
|
2023
Q2 | $23.7K | Buy |
251
+72
| +40% | +$6.79K | ﹤0.01% | 721 |
|
|
2023
Q1 | $18.1K | Buy |
179
+13
| +8% | +$1.32K | ﹤0.01% | 759 |
|
|
2022
Q4 | $20K | Buy |
166
+6
| +4% | +$723 | ﹤0.01% | 637 |
|
|
2022
Q3 | $17K | Buy |
160
+99
| +162% | +$10.5K | ﹤0.01% | 617 |
|
|
2022
Q2 | $6K | Sell |
61
-11
| -15% | -$1.08K | ﹤0.01% | 847 |
|
|
2022
Q1 | $7K | Buy |
72
+63
| +700% | +$6.13K | ﹤0.01% | 842 |
|
|
2021
Q4 | $1K | Buy |
+9
| New | +$1K | ﹤0.01% | 1262 |
|
|
2020
Q3 | – | Sell |
-6
| Closed | -$1K | – | 792 |
|
|
2020
Q2 | $1K | Buy |
+6
| New | +$1K | ﹤0.01% | 702 |
|
|
2017
Q2 | – | Sell |
-10
| Closed | -$433 | – | 1079 |
|
|
2017
Q1 | $433 | Sell |
10
-55
| -85% | -$2.38K | ﹤0.01% | 959 |
|
|
2016
Q4 | $2.52K | Buy |
+65
| New | +$2.52K | ﹤0.01% | 574 |
|
|
2016
Q2 | $221K | Buy |
4,863
+95
| +2% | +$4.32K | 0.03% | 304 |
|
|
2016
Q1 | $189K | Buy |
+4,768
| New | +$189K | 0.03% | 294 |
|